2,3-Dihydro-1H-indene-4-carbaldehyde - CAS 51932-70-8
Catalog: |
BB055817 |
Product Name: |
2,3-Dihydro-1H-indene-4-carbaldehyde |
CAS: |
51932-70-8 |
Synonyms: |
2,3-Dihydro-1H-indene-4-carboxaldehyde; 2,3-Dihydro-1H-inden-7-ylaldehyde;2,3-Dihydro-1H-indene-4-carbaldehyde; 4-Formylindan; 4-Formylindane; 4-Indancarboxaldehyde; Indan-4-carbaldehyde; Indane-4-carboxaldehyde |
IUPAC Name: | 2,3-dihydro-1H-indene-4-carbaldehyde |
Description: | 2,3-Dihydro-1H-indene-4-carbaldehyde is a useful reagent for preparing sulfonylurea compounds for treating conditions associated with NLRP activity. |
Molecular Weight: | 146.19 |
Molecular Formula: | C10H10O |
Canonical SMILES: | C1CC2=C(C1)C(=CC=C2)C=O |
InChI: | InChI=1S/C10H10O/c11-7-9-5-1-3-8-4-2-6-10(8)9/h1,3,5,7H,2,4,6H2 |
InChI Key: | VAZZQRFSDNZKPO-UHFFFAOYSA-N |
References: | Franchi, L., et al. PCT Int. Appl. (2020), WO 2020102576 A1. |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020126841-A1 | Moisture-curing polyurethane composition containing oxazolidine | 20181217 |
BR-112021009141-A2 | moisture curing polyurethane composition containing oxazolidine | 20181217 |
CN-113272299-A | Moisture-curing polyurethane composition comprising oxazolidine | 20181217 |
EP-3898619-A1 | Moisture-curing polyurethane composition containing oxazolidine | 20181217 |
US-2022025176-A1 | Moisture-curing polyurethane composition containing oxazolidine | 20181217 |
WO-2020102576-A1 | Compounds and compositions for treating conditions associated with nlrp activity | 20181116 |
TW-202033504-A | Compounds and compositions for treating conditions associated with nlrp activity | 20181116 |
CN-113286784-A | Compounds and compositions for treating conditions associated with NLRP activity | 20181116 |
EP-3880659-A1 | Compounds and compositions for treating conditions associated with nlrp activity | 20181116 |
JP-2022507506-A | Compounds and compositions for treating conditions associated with NLRP activity | 20181116 |
Complexity: | 153 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 146.073164938 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 146.073164938 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 17.1Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[24292-52-2]
Hesperidin methyl chalcone
-
[55382-52-0]
Methyl Divarinolcarboxylate
-
[35045-02-4]
Metribuzin-desamino
-
[332360-02-8]
Mitoguazone dihydrochloride monohydrate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[172531-37-2]
Azido-PEG3-acetic acid
INDUSTRY LEADERS TRUST OUR PRODUCTS